SUMMARY Patients due for cataract extraction received 5 doses of 400 mg acyclovir (Zovirax) orally during the 24 hours prior to surgery. Aqueous humour levels of acyclovir (mean 3-26 uM) were well above the normal ED5o range for herpes simplex virus type 1, and showed a significant correlation with plasma concentrations (mean 8-74 ,M). There was also a correlation between the age of the patient and the concentration of acyclovir in the plasma. Oral acyclovir was well tolerated.
Acyclovir (9-(2-hydroxyethoxymethyl)guanine) is a potent antiviral agent (Zovirax) against herpes simplex virus types 1 and 2.' 21It acts selectively against the virus without eliciting any substantial toxic effect on uninfected cells. The first stage in the phosphorylation of acyclovir to its active triphosphate form is carried out by the virus-coded thymidine kinase but not by normal cellular enzymes. Acyclovir triphosphate selectively inhibits the viral DNA polymerase.3
Topical acyclovir was first demonstrated to be clinically effective in the treatment of superficial herpetic keratitis by Jones et al.4 Subsequent studies have shown it to be at least as effective5-7 as or more effective8-'2 than idoxuridine and adenine arabinoside and generally equivalent to trifluorothymidine. 13 The intraocular penetration of acyclovir is superior to that of other antiviral agents, and statistically and biologically significant concentrations of acyclovir have been found in the aqueous humour following topical application of the ophthalmic ointment to patients about to undergo cataract surgery. 14 Anecdotal evidence'5 suggests that systemic therapy with intravenous acyclovir is also effective in the treatment of herpetic keratitis, and therapeutic concentrations of the drug have been demonstrated in the plasma following oral administration. "I" Nevertheless, as an indication of the possible role of systemic therapy in the treatment ofherpetic keratitis, especially the deeper forms ofinfection, it is necessary to determine the concentrations of acyclovir achieved in the aqueous humour after oral dosing. In this study we have investigated the penetration of orally administered acyclovir into the aqueous humour of patients undergoing cataract surgery.
Patients and methods
Twenty patients due for cataract extraction, aged over 18 years and who gave their informed consent, humour and the plasma. Linear regre (Fig. 2) 
